895
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Radiofrequency ablation for papillary thyroid cancer located in isthmus: comparison with that originated in thyroid lobe

ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon show all
Article: 2266668 | Received 19 Jun 2023, Accepted 29 Sep 2023, Published online: 08 Nov 2023

References

  • Gandolfi G, Sancisi V, Piana S, et al. Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma. Int J Cancer. 2015;137(5):1001–1011. doi: 10.1002/ijc.28976.
  • Megwalu UC, Moon PK. Thyroid cancer incidence and mortality trends in the United States: 2000-2018. Thyroid. 2022;32(5):560–570. doi: 10.1089/thy.2021.0662.
  • Miranda-Filho A, Lortet-Tieulent J, Bray F, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225–234. doi: 10.1016/S2213-8587(21)00027-9.
  • Song Q, Gao H, Tian X, et al. Evaluation of ultrasound-guided radiofrequency ablation as a treatment option for papillary thyroid microcarcinoma in the isthmus: a retrospective study. Front Endocrinol. 2020;11:599471. doi: 10.3389/fendo.2020.599471.
  • Goldfarb M, Rodgers SS, Lew JI. Appropriate surgical procedure for dominant thyroid nodules of the isthmus 1 cm or larger. Arch Surg. 2012;147(9):881–884. doi: 10.1001/archsurg.2012.728.
  • Lee YS, Jeong JJ, Nam KH, et al. Papillary carcinoma located in the thyroid isthmus. World J Surg. 2010;34(1):36–39. doi: 10.1007/s00268-009-0298-6.
  • Nixon IJ, Palmer FL, Whitcher MM, et al. Thyroid isthmusectomy for well-differentiated thyroid cancer. Ann Surg Oncol. 2011;18(3):767–770. doi: 10.1245/s10434-010-1358-8.
  • Jasim S, Baranski TJ, Teefey SA, et al. Investigating the effect of thyroid nodule location on the risk of thyroid cancer. Thyroid. 2020;30(3):401–407. doi: 10.1089/thy.2019.0478.
  • Vasileiadis I, Boutzios G, Karalaki M, et al. Papillary thyroid carcinoma of the isthmus: total thyroidectomy or isthmusectomy? Am J Surg. 2018;216(1):135–139. doi: 10.1016/j.amjsurg.2017.09.008.
  • Ramundo V, Lamartina L, Falcone R, et al. Is thyroid nodule location associated with malignancy risk? Ultrasonography. 2019;38(3):231–235. doi: 10.14366/usg.18050.
  • Wang TS, Sosa JA. Thyroid surgery for differentiated thyroid cancer - recent advances and future directions. Nat Rev Endocrinol. 2018;14(11):670–683. doi: 10.1038/s41574-018-0080-7.
  • Zheng L, Dou JP, Liu FY, et al. Microwave ablation vs. surgery for papillary thyroid carcinoma with minimal sonographic extrathyroid extension: a multicentre prospective study. Eur Radiol. 2023;33(1):233–243. doi: 10.1007/s00330-022-08962-6.
  • Yan L, Zhang M, Song Q, et al. Ultrasound-guided radiofrequency ablation versus thyroid lobectomy for low-risk papillary thyroid microcarcinoma: a propensity-matched cohort study of 884 patients. Thyroid. 2021;31(11):1662–1672. doi: 10.1089/thy.2021.0100.
  • Kim HJ, Chung SM, Kim H, et al. Long-term efficacy of ultrasound-guided laser ablation for papillary thyroid microcarcinoma: results of a 10-year retrospective study. Thyroid. 2021;31(11):1723–1729. doi: 10.1089/thy.2021.0151.
  • Cho SJ, Baek SM, Na DG, et al. Five-year follow-up results of thermal ablation for low-risk papillary thyroid microcarcinomas: systematic review and meta-analysis. Eur Radiol. 2021;31(9):6446–6456. doi: 10.1007/s00330-021-07808-x.
  • Mauri G, Orsi F, Carriero S, et al. Image-guided thermal ablation as an alternative to surgery for papillary thyroid microcarcinoma: preliminary results of an Italian experience. Front Endocrinol (Lausanne). 2020;11:575152. doi: 10.3389/fendo.2020.575152.
  • Cao XJ, Zhao ZL, Wei Y, et al. Microwave ablation for papillary thyroid cancer located in the thyroid isthmus: a preliminary study. Int J Hyperthermia. 2021;38(1):114–119. doi: 10.1080/02656736.2021.1880028.
  • Zheng L, Liu FY, Yu J, et al. Thermal ablation for papillary thyroid microcarcinoma located in the isthmus: a study with 3 years of follow-up. Future Oncol. 2022;18(4):471–480. doi: 10.2217/fon-2021-0463.
  • Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618. doi: 10.1089/thy.2018.0604.
  • Tessler FN, Middleton WD, Grant EG, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587–595. doi: 10.1016/j.jacr.2017.01.046.
  • Xiao J, Zhang Y, Yan L, et al. Ultrasonography-guided radiofrequency ablation for solitary T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a retrospective comparative study. Eur J Endocrinol. 2021;186(1):105–113. doi: 10.1530/EJE-21-0580.
  • Kim JH, Baek JH, Lim HK, et al. 2017 Thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19(4):632–655. doi: 10.3348/kjr.2018.19.4.632.
  • Zhang M, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up. Thyroid. 2020;30(3):408–417. doi: 10.1089/thy.2019.0147.
  • Cho SJ, Baek SM, Lim HK, et al. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors. Thyroid. 2020;30(12):1745–1751. doi: 10.1089/thy.2020.0106.
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):241–260. doi: 10.1148/radiol.14132958.
  • Baek JH, Lee JH, Sung JY, et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262(1):335–342. doi: 10.1148/radiol.11110416.
  • Haukoos JS, Lewis RJ. The propensity score. JAMA. 2015;314(15):1637–1638. doi: 10.1001/jama.2015.13480.
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi: 10.1089/thy.2015.0020.
  • Zhu P, Zhang Q, Wu Q, et al. Barriers and facilitators to the choice of active surveillance for low-risk papillary thyroid cancer in China: a qualitative study examining patient perspectives. Thyroid. 2023;33(7):826–834. doi: 10.1089/thy.2022.0347.
  • Brito JP, Ito Y, Miyauchi A, et al. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 2016;26(1):144–149. doi: 10.1089/thy.2015.0178.
  • Kwon O, Lee S, Bae JS, et al. Thyroid isthmusectomy with prophylactic central compartment neck dissection is a feasible approach for papillary thyroid cancer on the isthmus. Ann Surg Oncol. 2021;28(11):6603–6612. doi: 10.1245/s10434-021-09833-y.
  • Park H, Harries V, McGill MR, et al. Isthmusectomy in selected patients with well-differentiated thyroid carcinoma. Head Neck. 2020;42(1):43–49. doi: 10.1002/hed.25968.
  • Mauri G, Hegedüs L, Bandula S, et al. European thyroid association and cardiovascular and interventional radiological society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur Thyroid J. 2021;10(3):185–197. doi: 10.1159/000516469.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208. doi: 10.1038/nrc3672.
  • He H, Zhang Y, Song Q, et al. Nomogram prediction for the involution of the ablation zone after radiofrequency ablation treatment in patients with low-risk papillary thyroid carcinoma. Int J Hyperthermia. 2021;38(1):1133–1139. doi: 10.1080/02656736.2021.1960434.
  • Ma B, Wei W, Xu W, et al. Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: a retrospective case review and literature review. Thyroid. 2018;28(9):1134–1142. doi: 10.1089/thy.2017.0558.
  • Ge M, Xu D, Yang A, et al. Expert consensus on thermal ablation for thyroid benign nodes, microcarcinoma and metastatic cervical lymph nodes (2018 edition). China Cancer. 2018;27:768–773.
  • Yan L, Luo Y, Zhang Y, et al. The clinical application of core-needle biopsy after radiofrequency ablation for low-risk papillary thyroid microcarcinoma: a large cohort of 202 patients study. J Cancer. 2020;11(18):5257–5263. doi: 10.7150/jca.42673.
  • Karatzas T, Charitoudis G, Vasileiadis D, et al. Surgical treatment for dominant malignant nodules of the isthmus of the thyroid gland: a case control study. Int J Surg. 2015;18:64–68. doi: 10.1016/j.ijsu.2015.04.039.
  • Zhao H, Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases. Eur J Radiol. 2019;112:14–21. doi: 10.1016/j.ejrad.2019.01.006.
  • Lei J, Zhu J, Li Z, et al. Surgical procedures for papillary thyroid carcinoma located in the thyroid isthmus: an intention-to-treat analysis. Onco Targets Ther. 2016;9:5209–5216. doi: 10.2147/OTT.S106837.
  • Gui Z, Wang Z, Xiang J, et al. Comparison of outcomes following thyroid isthmusectomy, unilateral thyroid lobectomy, and total thyroidectomy in patients with papillary thyroid microcarcinoma of the thyroid isthmus: a retrospective study at a single center. Med Sci Monit. 2020;26:e927407. doi: 10.12659/MSM.927407.
  • Huang H, Yan D, Liu W, et al. Isthmectomy is effective and sufficient for selected patients with the isthmus-confined solitary papillary thyroid carcinoma. Asian J Surg. 2022;45(9):1678–1681. doi: 10.1016/j.asjsur.2021.08.074.
  • Kim C, Lee JH, Choi YJ, et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur Radiol. 2017;27(8):3128–3137. doi: 10.1007/s00330-016-4690-y.